ASP-7657
Category:
Inhibitor
Not Intended for Therapeutic Use. For research use only.
COA:
Inquire
Description:
ASP-7657 is an analgesics and anti-inflammatories for the treatment of diabetic neuropathies developed by Astellas Pharma. A phase I clinical trial to evaluate the safety and tolerability of single and multiple ascending oral doses of ASP7657 in healthy subjects was started in 2014 but discontinued in 2015.
Publictions citing BOC Sciences Products
  • >> More
Brife Description:
analgesics and anti-inflammatories, diabetic neuropathies
Purity:
≥98%
Appearance:
Solid powder
MSDS:
Inquire
Application:
An analgesics and anti-inflammatories for the treatment of diabetic neuropathies.
Current Developer:
Astellas Pharma Europe B.V.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Quick Inquiry

Verification code

Featured Items